Las vacunas más exitosas utilizadas en la actualidad han sido desarrolladas utilizando
métodos convencionales que siguen el paradigma establecido por Pasteur hace más de un …

Virus-like particles (VLPs) are a class of subunit vaccines that differentiate themselves from
soluble recombinant antigens by stronger protective immunogenicity associated with the …

Viruslike particles (VLPs) are nonreplicating, virus capsids made using recombinant DNA
technology that mimic the structure of native virions [1, 2]. They generally are formed when …

Vaccination is considered one of the most effective ways to control pathogens and prevent
diseases in humans as well as in the veterinary field. Traditional vaccines against animal …

Virus-like particles (VLPs) have become a key tool for vaccine developers and
manufacturers. They can be broadly used to develop prophylactic as well as therapeutic …

Vaccination continues to be the main approach to protect animals from infectious diseases.
Until recently, all licensed vaccines were developed using conventional technologies …

Virus-like particles (VLPs) are nanostructures that resemble the structures of viruses. They
are composed of one or more structural proteins that can be arranged in several layers and …

“... virus-like particles offer several valuable features and represent a very appealing model...
currently considered to be the best alternative vaccine approach for specific viral infections …

Vaccines are among the most successful and cost-effective public health tools for preventing
infectious diseases and death. Virus-like particles (VLPs) have made impressive progress in …

Virus-like particles (VLPs) have made giant strides in the field of vaccinology over the last
three decades. VLPs constitute versatile tools in vaccine development due to their …